samedan logo
 
 
spacer
home > ict > autumn 2008 > pen power
PUBLICATIONS
International Clinical Trials

Pen Power

With continued time and cost pressure on the drug development process, the days of clinical investigators using a traditional pen to complete case report forms (CRFs) may be numbered. Relying on the accurate collection and analysis of large amounts of patient data, clinical trials are responsible for around 40 per cent of the $1 billion cost typically incurred for developing a new drug. It is, therefore, not surprising that clinical trials have long been targeted by those looking for efficiencies in the costly and time-consuming drug approval process.

Today, contract research organisations (CROs) are increasingly relying on technology to speed up the data capturing process. One technology that is building a growing support base within the industry is digital pen and paper (DP&P). CROs and pharmaceutical companies have found the pen to significantly speed up data entry while also making it more accurate than paper entry or web-based data capture. More importantly, it has been shown that the digital pen can be a critical element of a clinical trials approach that can save several millions in cost and significantly shorten development time.

CONVENTIONAL ELECTRONIC CAPTURE

CROs that already use laptops, tablet PCs or PDAs to capture patient information more efficiently often find that these devices need considerable user training, can be impersonal, and increase administration effort at the expense of patient time – with an obvious impact on clinical trial economics. Conversely, DP&P, a relative newcomer in the...

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
After studying at Uppsala University, Sweden, Urban Fröderberg started his career in the pharmaceutical industry with Boehringer Ingelheim. In 1988, he then joined Sweden’s Astra, where he held several positions within the marketing and sales organisation. After Astra’s merger with Zeneca in 1999, Urban worked in a number of marketing and business development roles. He joined Anoto in August 2007, the company that invented digital pen and paper technology. Urban serves as Anoto’s Business Area Manager, Healthcare, focusing on the application of digital pen and paper in healthcare and the life sciences.
spacer
Urban Fröderberg
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nemera and Noble announce collaboration to support patients who self-administer medication

Nemera is excited to leverage the new collaboration to expand end-to- end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices
More info >>

White Papers

The Key To Tableting Success: How To Choose The Right Tooling

Natoli Engineering Company, Inc.

Choosing the right tooling can increase tablet output, decrease waste and ultimately determine the success of a product launch.
More info >>

 
Industry Events

Clinical Operations in Oncology Trials West Coast

17-18 November 2020, Hilton San Francisco Airport Bayfront

Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement